Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/656034


The North America Biotechnology Sectors : A Company and Industry Analysis (October 2003)


Description: Current Environment - Key Points
- The combined total revenue of ten of the top revenue-earning biotech companies in the US in 2002 was approximately $200,348,498,000
- Although the biotech Index hit an all-time low of 464.93 in September 2002 and peaked in August 2003 at 740.84, underlining the fact that 2002 was a brutal year, there has been a rapid recovery in 2003
- Major end markets include biotech crops, which are generally accepted by American consumers, although doubt persists for Europeans; as well as the biopharmaceutical sector, which is introducing a flurry of new drugs to the healthcare industry
- Worldwide biotech merger and acquisition volume increased from $1.58 billion in 2001 to $5.22 billion in 2002 with the number of transactions increasing from 13 in 2001 to a record 18 in 2002
- Recent estimates from the Biotechnology Industry Organization indicate that biotech funding from biotech-pharma alliances exceed $5 billion a year, representing an annual growth rate of more than 40%
- Several Canadian biotech companies are changing the future landscape of the Canadian biotech industry
Despite some major successes, the main concern lies in the viability of biotech companies with less than 18 months of cash on hand
- Canadian public company revenues reached $1,466 million, up 44% over 2002
In 2002, market capitalization decreased by 31% to $8,867 million from $12,909 million in 2001

Industry Profile - Key Points
- As at mid-April, the total value of US publicly traded companies- at market prices was $206 billion
- Encouraging study results on biotech drugs, coupled with a new US Food & Drug commissioner and a general willingness to take on riskier investments, has sent biotech stocks up since the start of 2003, which bodes well for the venture capital market
- The top five US companies spent an average of $133,600 per employee on R&D, approximately 20% of their revenue, while pharmaceuticals spent only 11%
- The FDA's fiscal year 2003 budget request was $1.7 billion, a net increase of $123 million over fiscal year 2002
- In late August 2003, the World Trade Organization agreed to give poor nations greater access to inexpensive, life-saving medicine by altering international trade rules; poor countries will be able to import generic versions of expensive patented medicines, buying from countries like India and Brazil, without breaking the trade laws that protect patent rights
- Canada, ranked number two in the world, is home to an estimated 417 biotech companies with more than 6,500 products at various stages of development
- According to government statistics, Canadian companies are showing strong R&D commitment, undertaking investments of $950.5 million in 2001, up 57.3% over 1999 research and development expenditure of $604.6 million
Market Trends and Outlook - Key Points
- Genetically modified food (GM food) and agricultural biotechnology is constantly in the limelight, generating both interest and controversy, throughout the world
- With an increasing world population and a slowdown in the rate of crop improvement, biotechnology makes farming less time consuming
It also helps nations outside the US and Canada achieve results in agriculture and food production that conventional plant breeding would not allow
- Despite a difficult financing situation in 2002, the biotech sector raised more than $6 billion (including partnerships) in Q2 2003
- Information technology helps researchers to connect the different scientific disciplines involved in drug discovery


Contents: Current Environment - US
- Sector Overview
- Biotech Stocks Continue to Gain
Ground
- Major End Markets
- Leading Players
- Merger and Alliance Activity
- Alliances: Biotech and
Pharmaceuticals
Current Environment - Canada
- A Burgeoning Industry
- Industry Characteristics
- Leading Companies
- The IPO Scene
- Consolidation
Industry Profile - US
- The US: A World Leader
- Venture Capital Investment
- R&D: The Biotech Driver
- Research and Development
Expenditure
- Sector Investment
- Government Investment
- Policy and Regulatory
Environment
Industry Profile - Canada
- Industry Size and Value
- Research and Development
- Biotech Financing
- Government Investment
- Policy and Regulatory
Environment
Market Trends & Outlook
- Genetically Modified Crops on
the Rise
- Increasing Population and the
Role of Biotech in Food Supplies
- Biotech Companies Return to the
Black
- Leveraging IT to Generate
Biotechnology
- Healthy Employment Prospects
The Scope of this Report
Key References
Comparative Data
Sales Contacts




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/656034

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 23/11/2009 11:42:11
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
The North America Biotechnology Sectors : A Company and Industry Analysis (October 2003)
Web Address:
http://www.researchandmarkets.com/reports/656034
Office Code:
OC8HJMSMOVUUX

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €100.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 23/11/2009 11:42:11

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)